Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Bódi, Beáta"'
Autor:
Szőke, Kitti1 (AUTHOR), Bódi, Beáta2 (AUTHOR), Hendrik, Zoltán3 (AUTHOR), Czompa, Attila1 (AUTHOR), Gyöngyösi, Alexandra1,4 (AUTHOR), Haines, Donald David5 (AUTHOR), Papp, Zoltán2,6 (AUTHOR), Tósaki, Árpád1,7 (AUTHOR), Lekli, István1,4 (AUTHOR) lekli.istvan@pharm.unideb.hu
Publikováno v:
Pharmacology Research & Perspectives. Jun2023, Vol. 11 Issue 3, p1-11. 11p.
Autor:
Ruppert, Mihály, Bódi, Beáta, Korkmaz-Icöz, Sevil, Loganathan, Sivakkanan, Jiang, Weipeng, Lehmann, Lorenz, Oláh, Attila, Barta, Bálint András, Sayour, Alex Ali, Merkely, Béla, Karck, Matthias, Papp, Zoltán, Szabó, Gábor, Radovits, Tamás
Publikováno v:
In Journal of Molecular and Cellular Cardiology April 2019 129:208-218
Autor:
Bódi, Beáta, Tóth, Enikő Pásztorné, Nagy, László, Tóth, Attila, Mártha, Lilla, Kovács, Árpád, Balla, György, Kovács, Tamás, Papp, Zoltán
Publikováno v:
In Free Radical Biology and Medicine December 2017 113:224-235
Autor:
Lódi, Mária, Bánhegyi, Viktor, Bódi, Beáta, Gyöngyösi, Alexandra, Kovács, Árpád, Árokszállási, Anita, Hamdani, Nazha, Fagyas, Miklós, Édes, István, Csanádi, Zoltán, Czuriga, István, Kisvárday, Zoltán, Lekli, István, Bai, Péter, Tóth, Attila, Papp, Zoltán, Czuriga, Dániel
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-18 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background Cardiomyopathy is a common side effect of doxorubicin (DOX) chemotherapy. Despite intensive research efforts in the field, there is still no evidence available for routine cardioprotective prophylaxis to prevent cardiotoxicity in the major
Autor:
Ladányi, Zsuzsanna, Ruppert, Mihály, Fabian, Alexandra, Adrienn, Ujvári, Turschl, Tímea, Bódi, Beáta, Papp, Zoltán, Bálint, Tímea, Nagy, Dávid, Radovits, Tamás, Molnár, Levente, Straub, Éva, Nagy, Andrea, Kovács, Attila, Merkely, Bela, Lakatos, Bálint Károly
Publikováno v:
In Journal of the American College of Cardiology 2 April 2024 83(13) Supplement:1448-1448
Autor:
Bódi, Beáta, Kovács, Árpád, Gulyás, Hajnalka, Mártha, Lilla, Tóth, Attila, Mátyás, Csaba, Barta, Bálint András, Oláh, Attila, Merkely, Béla, Radovits, Tamás, Papp, Zoltán
Publikováno v:
Antioxidants, Vol 10, Iss 1776, p 1776 (2021)
Antioxidants
Volume 10
Issue 11
Antioxidants
Volume 10
Issue 11
Heart failure with preserved ejection fraction (HFpEF) and right ventricular (RV) dysfunction are frequent complications of diabetic cardiomyopathy. Here we aimed to characterize RV and left ventricular (LV) remodeling and its prevention by vardenafi
Autor:
Bódi, Beáta, Pilz, Patrick M., Mártha, Lilla, Lang, Miriam, Hamza, Ouafa, Fagyas, Miklós, Szabó, Petra L., Abraham, Dietmar, Tóth, Attila, Podesser, Bruno K., Kiss, Attila, Papp, Zoltán
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 11064, p 11064 (2021)
Volume 22
Issue 20
International Journal of Molecular Sciences, Vol 22, Iss 11064, p 11064 (2021)
Volume 22
Issue 20
Post-ischemic left ventricular (LV) remodeling and its hypothetical prevention by repeated remote ischemic conditioning (rRIC) in male Sprague–Dawley rats were studied. Myocardial infarction (MI) was evoked by permanent ligation of the left anterio
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lódi, Mária, Priksz, Dániel, Fülöp, Gábor Áron, Bódi, Beáta, Gyöngyösi, Alexandra, Nagy, Lilla, Kovács, Árpád, Kertész, Attila Béla, Kocsis, Judit, Édes, István, Csanádi, Zoltán, Czuriga, István, Kisvárday, Zoltán, Juhász, Béla, Lekli, István, Bai, Péter, Tóth, Attila, Papp, Zoltán, Czuriga, Dániel
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-16 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background Chemotherapy-induced left ventricular dysfunction represents a major clinical problem, which is often only recognised at an advanced stage, when supportive therapy is ineffective. Although an early heart failure treatment could positively